AnodyneWiki

2,5-Dimethoxy-4-methylamphetamine

DOM
2,5-Dimethoxy-4-methylamphetamine
Salts
[]
2,5-Dimethoxy-4-methylamphetamine hydrochloride
2,5-Dimethoxy-4-methylamphetamine hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass209.28 g/mol [1]
Melting point60.5 to 60.1 °C [1]
DecompositionWhen heated to decomposition it emits toxic vapors of /Nitrogen oxides/. [1]
Predicted LogP2.2 [1]
Structural Identifiers
[]
Molecular formulaC12H19NO2
IUPAC name1-(2,5-dimethoxy-4-methylphenyl)propan-2-amine
SMILESCC1=CC(=C(C=C1OC)CC(C)N)OC
InChIInChI=1S/C12H19NO2/c1-8-5-12(15-4)10(6-9(2)13)7-11(8)14-3/h5,7,9H,6,13H2,1-4H3
InChIKeyNTJQREUGJKIARY-UHFFFAOYSA-N
CAS number15588-95-1
UNIIUKI9MLD5OI
PubChem CID85875
Pharmacokinetics[]
Onset0.5–1.5 hours, Peak: 2–6 hours
Duration of actionLow doses: 5–8 hours, Moderate doses: 8–24 hours, High doses: possibly up–3–4 days
MetabolismDemethylation
Excretion5–20% unchanged
Routes of administrationOral
Toxicity
[]
Mouse:
- ip: 89 +
- ip: 94 mg/kg
Rabbit:
- oral: 200 mg/kg
 [1]

2,5-Dimethoxy-4-methylamphetamine (also known as STP (hallucinogen), (rs)-dom, 2,5-Dimethoxymethylamphetamine, dl-2,5-Dimethoxy-4-methylamphetamine, 4-Methyl-2,5-dimethoxyamphetamine, dl-4-Methyl-2,5-dimethoxyamphetamine, 2',5'-Dimethoxy-4'-methylamphetamine, 2,5-Dimethoxy-4-methylphenylisopropylamine, (+-)-dom or 2,5-Dimethoxy-4,α-dimethylphenethylamin) is a psychedelic substance of the amphetamine and 2,5-dimethoxyamphetamine class.

Chemistry

Salts []

2,5-Dimethoxy-4-methylamphetamine is typically found in the form of its hydrochloride salt.

 []

2,5-Dimethoxy-4-methylamphetamine is a racemic mixture of the (optical activity ( + / - )).

Stereoisomers from PubChem

2,5-Dimethoxy-4-methylamphetamine matches Lipinski's rule of five.

There are currently 10 reagent-interactions on

ReagentColor changeDescription
Marquisno color change
Meckeyellow > green > brown
Mandelingreen
Liebermannyellow > black
Froehdeyellow > green
Robadopeno pink color change
Simon'sno blue color change
Ehrlichno color change
Hofmannlight yellow
Scottno color change

Pharmacology

Mechanism of action []

Alterations in brain serotonergic function have been implicated in the mechanism of action of LSD, mescaline, and other similarly acting hallucinogenic drugs of abuse such as STP (2,5-dimethoxyphenylisopropylamine; DOM). In order to test the hypothesis that the mechanism of action of LSD and phenylisopropylamine hallucinogens is through stimulation of a specific brain serotonin receptor sub-type, the affinities of these compounds for radiolabelled 5-HT2, 5-HT1A, 5-HT1B, and 5-HT1C receptors have been determined using recently developed in vitro radioligand binding methodologies. The 5-HT2 receptor was labelled with the agonist/hallucinogen radioligand 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine). The 5-HT1A, 5-HT1B, and 5-HT1C receptors were labelled with 3H-OH-DPAT, 3H-5-HT, and 3H-mesulergine, respectively. In general, the phenylisopropylamines displayed 10-100 fold higher affinities for the 5-HT2 receptor than for the 5-HT1C receptor and 100-1000 fold higher affinities for the 5-HT2 receptor than for the 5-HT1A or 5-HT1B receptor. There was a strong correlation between hallucinogenic potencies and 5-HT2 receptor affinities of the phenylisopropylamines (r = 0.90); the correlation coefficients for the 5-HT1A, 5-HT1B, and 5-HT1C were 0.73, 0.85, and 0.78, respectively. Because there is no evidence that 5-HT1A-selective or 5-HT1B-selective agonists are hallucinogenic and because the phenylisopropylamines are potent hallucinogens, a 5-HT2 receptor interaction is implicated and supports previous suggestions to this effect. A secondary role for 5-HT1C receptors cannot be discounted at this time. [1]

Subjective effects []

nervewing / 2,5-Dimethoxy-4-methylamphetamine []

Experience reports

Erowid

There are currently 30 experience reports involving 2,5-dimethoxy-4-methylamphetamine on : []

 []

  • Australia: 2,5-Dimethoxy-4-methylamphetamine is a Schedule 9.
  • Brazil: 2,5-Dimethoxy-4-methylamphetamine is a F2.[3]
  • Canada: 2,5-Dimethoxy-4-methylamphetamine is a Schedule I.
  • United Kingdom: 2,5-Dimethoxy-4-methylamphetamine is a Class A under the "Misuse of Drugs Act 1971".
  • United States: 2,5-Dimethoxy-4-methylamphetamine is a Schedule I under the "Controlled Substances Act".

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 85875, 2,5-Dimethoxy-4-methylamphetamine. Accessed November 22, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/85875
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. 2,5-Dimethoxy-4-methylamphetamine. UNII: UKI9MLD5OI. Global Substance Registration System. Accessed November 22, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/UKI9MLD5OI
  3. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-07-24. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 04:06:53
drugsprook2026-11-20 04:06:49
erowidok2026-11-20 04:06:52
gsrsok2026-11-20 04:06:50
hmdbmissing (hmdb.ca refused automated access to HMDB0245501)2026-11-20 04:06:49
keggmissing (no KEGG DRUG entry)2026-11-20 04:06:54
pubchemok2026-11-20 04:06:48
redditmissing (no r/tripreports posts mention it)2026-11-20 04:06:49
sidermissing (not in SIDER)2026-11-20 04:06:49
structureok2026-11-20 04:06:49
wikipediaok2026-11-20 04:06:50